Literature DB >> 7828751

Endothelin-1 levels in ischaemia, reperfusion, and haemorrhagic shock in the canine infrarenal aortic revascularisation model.

J D Edwards1, P S Dovgan, J M Rowley, D K Agrawal, P E Thorpe, T E Adrian.   

Abstract

Endothelin-1 (ET-1) is a potent vasoconstrictive polypeptide produced from vascular endothelial cells. The effects of ischaemia, reperfusion, and exsanguination on plasma ET-1 levels were studied and compared in the mongrel dog after infrarenal aortic cross clamping. Ischaemia produced a trend toward increased ET-1 serum levels (p < 0.07 with Bonferroni correction) that did not reach significance. Plasma ET-1 levels were significantly increased during reperfusion and even further elevations were found following exsanguination. We found a 2-3 fold increase in ET-1 levels following reperfusion (Initial 3.19 +/- 0.27 pg/ml vs. Reperfusion maximum 6.32 +/- 0.72 pg/ml, Bonferroni p < 0.01). Haemorrhagic shock was associated with a 3-4 fold increase in ET-1 levels (Initial 3.19 +/- 0.27 pg/ml vs. Exsanguination maximum 8.37 +/- 0.97 pg/ml Bonferroni p < 0.001). These data reveal that ET-1 is released during reperfusion and exsanguination and may mediate remote vascular events associated with infrarenal aortic cross clamping and acute blood loss.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7828751     DOI: 10.1016/s0950-821x(05)80654-1

Source DB:  PubMed          Journal:  Eur J Vasc Surg        ISSN: 0950-821X


  2 in total

1.  Endothelin-1 induces tyrosine phosphorylation in human blood monocytes.

Authors:  L J Chisholm; D K Agrawal; T J Pearson; J D Edwards
Journal:  Mol Cell Biochem       Date:  1996-06-07       Impact factor: 3.396

2.  Heat stress aggravates oxidative stress, apoptosis, and endoplasmic reticulum stress in the cerebellum of male C57 mice.

Authors:  Hajar Oghbaei; Leila Hosseini; Fereshteh Farajdokht; Sepideh Rahigh Aghsan; Alireza Majdi; Saeed Sadigh-Eteghad; Siamak Sandoghchian Shotorbani; Javad Mahmoudi
Journal:  Mol Biol Rep       Date:  2021-08-02       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.